Intravital fluorescence imaging of small interfering RNA-mediated gene repression in a dual reporter melanoma xenograft model

Nucleic Acid Therapeutics

Volumn 22, Issue 6, 2012, Pages 438-443

  Hickerson, Robyn P ^a   Gonzalez Gonzalez, Emilio ^b,e   Vlassov, Alexander V ^c   Li, Mu ^c   Lara, Maria Fernanda ^a   Contag, Christopher H ^d   Kaspar, Roger L ^a,d  

^a TransDerm Inc   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Life Technologies   (United States)

^d STANFORD UNIVERSITY   (United States)

^e Institute of Biomedical Research in Malaga and BIONAND Nanomedicine Platform   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FLUORESCENCE IMAGING; GENE REPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR MODEL; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; LENTIVIRUS; LUCIFERASES; MELANOMA; MICE; NEOPLASM TRANSPLANTATION; OPTICAL IMAGING; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; SKIN NEOPLASMS;

LYCOPERSICON ESCULENTUM;

EID: 84870568673     PISSN: 21593337     EISSN: None     Source Type: Journal    
DOI: 10.1089/nat.2012.0364     Document Type: Article

References (20)

1. BEHLKE, M. A. (2008). Chemical modification of siRNAs for in vivo use. Oligonucleotides 18, 305-319. (Pubitemid 352791344)
2. BURNETT, J. C., and J. J. ROSSI (2012). RNA-based therapeutics: current progress and future prospects. Chem. Biol. 19, 60-71.
3. FINN, L., S. N. MARKOVIC, et al. (2012). Therapy for metastatic melanoma: the past, present, and future. BMC Med. 10, 23.
4. GIARD, D. J., S. A. AARONSON, et al. (1973). In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 51, 1417-1423.
5. GONZALEZ-GONZALEZ, E., H. RA, et al. (2009). siRNA silencing of keratinocyte-specific GFP expression in a transgenic mouse skin model. Gene Ther. 16, 963-972.
6. GONZALEZ-GONZALEZ, E., T. J. SPEAKER, et al. (2010). Silencing of reporter gene expression in skin using siRNAs and expression of plasmid DNA delivered by a soluble protrusion array device (PAD). Mol. Ther. 18, 1667-1674.
7. GUIDA, M., S. PISCONTE, et al. (2012). Metastatic melanoma: the new era of targeted therapy. Expert Opin. Ther. Targets 16, S61-S70.
8. HICKERSON, R. P., M. A. FLORES, et al. (2011a). Use of selfdelivery siRNAs to inhibit gene expression in an organotypic pachyonychia congenita model. J. Invest. Dermatol. 131, 1037-1044.
9. HICKERSON, R. P., S. A. LEACHMAN, et al. (2011b). Development of quantitative molecular clinical end points for siRNA clinical trials. J. Invest. Dermatol. 131, 1029-1036.
10. HSU, T., and S. MITRAGOTRI (2011). Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer. Proc. Natl. Acad. Sci. U. S. A. 108, 15816-15821.
11. JACKSON, A. L., and P. S. LINSLEY (2010). Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat. Rev. Drug Discov. 9, 57-67.
12. KASPAR, R., W. MCLEAN, et al. (2009). Achieving successful delivery of nucleic acids to skin: 6th Annual Meeting of the International Pachyonychia Congenita Consortium. J. Invest. Derm. 129, 2085-2087.
13. KUDCHADKAR, R., K. H. PARAISO, et al. (2012). Targeting mutant BRAF in melanoma: current status and future development of combination therapy strategies. Cancer J. 18, 124-131.
14. KWON, S. Y., and S. J. MILLER (2011). Mohs surgery for melanoma in situ. Dermatol. Clin. 29, 175-183, vii-viii.
15. LEACHMAN, S. A., R. P. HICKERSON, et al. (2010). First-inhuman mutation-targeted siRNA phase 1b trial of an inherited skin disorder. Mol. Ther. 18, 442-446.
16. LIN, M. Z., M. R. MCKEOWN, et al. (2009). Autofluorescent proteins with excitation in the optical window for intravital imaging in mammals. Chem. Biol. 16, 1169-1179.
17. LIVAK, K. J., and T. D. SCHMITTGEN (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402-408. (Pubitemid 34164012)
18. MATRANGA, C., Y. TOMARI, et al. (2005). Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell 123, 607-620. (Pubitemid 41608464)
19. MONZON, J. G., and J. DANCEY (2012). Targeted agents for the treatment of metastatic melanoma. Onco. Targets Ther. 5, 31-46.
20. SOUTSCHEK, J., A. AKINC, et al. (2004). Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432, 173-178. (Pubitemid 39545841)